BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11515200)

  • 1. [Iatrogenic torsades de pointes].
    Hennemann A
    Med Monatsschr Pharm; 2001 Aug; 24(8):262-5. PubMed ID: 11515200
    [No Abstract]   [Full Text] [Related]  

  • 2. Towards a drug concentration effect relationship for QT prolongation and torsades de pointes.
    Webster R; Leishman D; Walker D
    Curr Opin Drug Discov Devel; 2002 Jan; 5(1):116-26. PubMed ID: 11865665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-induced prolongation of the QT interval.
    Curigliano G; Cipolla C; de Braud F
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias.
    Thomsen MB; Matz J; Volders PG; Vos MA
    Pharmacol Ther; 2006 Oct; 112(1):150-70. PubMed ID: 16714061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case report. Torsades de pointes caused by overdose of thioridazine].
    Näsh O; Rydenhag A
    Lakartidningen; 1993 Oct; 90(42):3677-8, 3681. PubMed ID: 8231516
    [No Abstract]   [Full Text] [Related]  

  • 6. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.
    Amankwa K; Krishnan SC; Tisdale JE
    Clin Pharmacol Ther; 2004 Mar; 75(3):242-7. PubMed ID: 15001976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torsades de pointes.
    Solomons HD
    Cardiovasc J Afr; 2011; 22(4):217. PubMed ID: 21881693
    [No Abstract]   [Full Text] [Related]  

  • 8. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
    Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
    Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
    [No Abstract]   [Full Text] [Related]  

  • 9. Frequently occurring Torsades de pointes attacks in an old patient on solifenacin therapy and management strategy.
    Özmen N; Yiğiner Ö; Ün H; Bıçakçı B
    Anatol J Cardiol; 2015 Apr; 15(4):342-3. PubMed ID: 25880296
    [No Abstract]   [Full Text] [Related]  

  • 10. The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes.
    Carlsson L
    Pharmacol Ther; 2008 Aug; 119(2):160-7. PubMed ID: 18558435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced prolongation of the QT interval.
    Cruciani RA; Portenoy RK; Homel P
    N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208786
    [No Abstract]   [Full Text] [Related]  

  • 12. Torsades de pointes ventricular tachycardia associated with terfenadine and paracetamol self medication.
    Matsis PP; Easthope RN
    N Z Med J; 1994 Oct; 107(987):402-3. PubMed ID: 7936480
    [No Abstract]   [Full Text] [Related]  

  • 13. Methadone-induced torsade de pointes.
    Nordt SP; Zilberstein J; Gold B
    Am J Emerg Med; 2011 May; 29(4):476.e1-2. PubMed ID: 20674223
    [No Abstract]   [Full Text] [Related]  

  • 14. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP; Kaab S; Hinterseer M; McNitt S; Xia X; Fossa A; Beckmann BM; Polonsky S; Zareba W
    J Clin Pharmacol; 2009 Jan; 49(1):6-16. PubMed ID: 18957528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines.
    Arbel Y; Swartzon M; Justo D
    Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs and the QT interval--implications for dentistry.
    Wynn RL
    Gen Dent; 2005; 53(2):94-7. PubMed ID: 15833006
    [No Abstract]   [Full Text] [Related]  

  • 17. Seventy-four defibrillations for sotalol-induced torsades de pointes.
    Sürücü H; Tatli E; Değirmenci A; Gökmen G
    Indian Heart J; 2004; 56(4):340-2. PubMed ID: 15586745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone induced Torsades de Pointes mimicking seizures in clinical presentation.
    Raina S; Paydak H; Al-Lahham T; Shihabuddin BS
    Am J Drug Alcohol Abuse; 2014 Nov; 40(6):490-2. PubMed ID: 25321151
    [No Abstract]   [Full Text] [Related]  

  • 19. Recognition and management of torsades de pointes.
    Greene TO; Spodick DH
    Heart Dis Stroke; 1992; 1(6):383-90. PubMed ID: 1344136
    [No Abstract]   [Full Text] [Related]  

  • 20. Ciprofloxacin-induced torsade de pointes.
    Flanagan MC; Mitchell ES; Haigney MC
    Int J Cardiol; 2006 Nov; 113(2):239-41. PubMed ID: 16386810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.